7-143960442-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012369.3(OR2F1):c.472G>A(p.Val158Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000812 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_012369.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2F1 | NM_012369.3 | c.472G>A | p.Val158Met | missense_variant | 3/3 | ENST00000641412.1 | NP_036501.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2F1 | ENST00000641412.1 | c.472G>A | p.Val158Met | missense_variant | 3/3 | NM_012369.3 | ENSP00000493004.1 | |||
OR2F1 | ENST00000624504.1 | c.472G>A | p.Val158Met | missense_variant | 1/1 | 6 | ENSP00000485483.1 | |||
OR2F1 | ENST00000470988.1 | n.146+1334G>A | intron_variant | 2 | ||||||
OR2F1 | ENST00000641986.1 | n.297-189G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251420Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135872
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727246
GnomAD4 genome AF: 0.000433 AC: 66AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74446
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at